Enhancing the Development and Bringing to Market of
New Dermatological Therapeutic Options
The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs, in the treatment of high unmet need.
The dermatology space continues to undergo huge therapeutic innovation and growing competitive pressure, driven by the evolving understanding of the pathophysiology of skin diseases, as well as in the available treatment options for chronic, moderate to severe dermatological conditions and high unmet need that affects the lives of patients worldwide.
The 3rd Annual Dermatology Drug Development Summit provides leading industry experts with a unique forum to debate the end-to-end challenges in dermatology drug development: from discovering new research on key disease pathways, to unveiling critical preclinical insights, discussing formulation strategies, defining the optimal clinical development plans or evaluating commercialization approaches.
Join peers and leaders in this space for an exclusive three-day meeting of comprehensive discussion, sharing of latest advances and pioneering insights, and networking opportunities.
Key Benefits of Attending:
Accelerate the development of innovative dermatological therapies
Hear from KOLs how to tackle the challenges to bring better dermatology drugs to market
Be in tune with growing excitement in the dermatology drug development space
2019 Featured Speakers
Head of New Treatment Strategies, Immune-Dermatology
Senior Director – Translational Research
VP & Head of North America Medical Affairs for Immunology
Proud to Partner With